Marco C. Cavaco

Dr. Aiguader 88, Barcelona Biomedical Research Park
Barcelona, CT 08003, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Linker Design in Antibody-Drug Conjugates: Balancing Stability and Drug Release.

Linker Design in Antibody-Drug Conjugates: Balancing Stability and Drug Release.

Journal: Pharmaceutics

Published: July 09, 2026

Comparative characterization of six teleost piscidins reveals distinct antimicrobial, antibiofilm and stability profiles.

Comparative characterization of six teleost piscidins reveals distinct antimicrobial, antibiofilm and stability profiles.

Journal: Fish & shellfish immunology

Published: June 28, 2026

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

Journal: Chemical science

Published: January 01, 2026

Antimigratory and Antiproliferative Effects of the Brain-Targeted Peptide Conjugate PepH3-vCPP2319 on Triple Negative Breast Cancer Cell Cultures.

Antimigratory and Antiproliferative Effects of the Brain-Targeted Peptide Conjugate PepH3-vCPP2319 on Triple Negative Breast Cancer Cell Cultures.

Journal: Journal of peptide science : an official publication of the European Peptide Society

Published: April 29, 2025

The Potential of Peptide-Based Inhibitors in Disrupting Protein-Protein Interactions for Targeted Cancer Therapy.

The Potential of Peptide-Based Inhibitors in Disrupting Protein-Protein Interactions for Targeted Cancer Therapy.

Journal: International journal of molecular sciences

Published: February 14, 2025

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.

Journal: Fluids and barriers of the CNS

Published: August 30, 2024

vCPP2319 interacts with metastatic breast cancer extracellular vesicles (EVs) and transposes a human blood-brain barrier model.

vCPP2319 interacts with metastatic breast cancer extracellular vesicles (EVs) and transposes a human blood-brain barrier model.

Journal: Heliyon

Published: April 06, 2024

The use of a selective, nontoxic dual-acting peptide for breast cancer patients with brain metastasis.

The use of a selective, nontoxic dual-acting peptide for breast cancer patients with brain metastasis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 18, 2024

Molecular determinants for brain targeting by peptides: a meta-analysis approach with experimental validation.

Molecular determinants for brain targeting by peptides: a meta-analysis approach with experimental validation.

Journal: Fluids and barriers of the CNS

Published: January 18, 2024

Quantitative Imaging of the Action of vCPP2319, an Antimicrobial Peptide from a Viral Scaffold, against Staphylococcus aureus Biofilms of a Clinical Isolate.

Quantitative Imaging of the Action of vCPP2319, an Antimicrobial Peptide from a Viral Scaffold, against Staphylococcus aureus Biofilms of a Clinical Isolate.

Journal: ACS infectious diseases

Published: September 05, 2023

Structural and Biochemical Characterization of Three Antimicrobial Peptides from Capsicum annuum L. var. annuum Leaves for Anti-Candida Use.

Structural and Biochemical Characterization of Three Antimicrobial Peptides from Capsicum annuum L. var. annuum Leaves for Anti-Candida Use.

Journal: Probiotics and antimicrobial proteins

Published: June 14, 2023

Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma.

Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma.

Journal: Frontiers in veterinary science

Published: June 07, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026